A novel approach to detect KRAS/BRAF mutation for colon cancer: Highly sensitive simultaneous detection of mutations and simple pre-treatment without DNA extraction

It has been reported that colon cancer patients with KRAS and BRAF mutations that lie downstream of epidermal growth factor receptor (EGFR) acquire resistance against therapy with anti-EGFR antibodies, cetuximab and panitumumab. On the other hand, some reports say KRAS codon 13 mutation (p.G13D) has...

Descripción completa

Detalles Bibliográficos
Autores principales: SUZUKI, SHUN-ICHI, MATSUSAKA, SATOSHI, HIRAI, MITSUHARU, SHIBATA, HARUMI, TAKAGI, KOICHI, MIZUNUMA, NOBUYUKI, HATAKE, KIYOHIKO
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485654/
https://www.ncbi.nlm.nih.gov/pubmed/25936694
http://dx.doi.org/10.3892/ijo.2015.2978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485654/
https://www.ncbi.nlm.nih.gov/pubmed/25936694
http://dx.doi.org/10.3892/ijo.2015.2978

Ejemplares similares